CIBC World Market
CORV

CIBC World Market’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

CIBC World Market’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-46,880
Closed -$18K – 1185
2020
Q1 		$18K Buy
+46,880
New +$17K ﹤0.01% 970
2017
Q3 		– Sell
-11,370
Closed -$51K – 1138
2017
Q2 		$51K Sell
11,370
-4,000
-26% -$14.5K ﹤0.01% 1117
2017
Q1 		$46K Buy
15,370
+5,000
+48% +$14.7K ﹤0.01% 974
2016
Q4 		$29K Sell
10,370
-400
-4% -$1.14K ﹤0.01% 1048
2016
Q3 		$34K Buy
+10,770
New +$39.3K ﹤0.01% 991

CIBC World Market's CORV Position: Q2 2020 in Review

CIBC World Market sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 46,880 shares — an estimated $18K sold.

CIBC World Market first reported a position in CORV in Q3 2016 and held it in 5 quarters. The position peaked at $51K in Q2 2017. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • CIBC World Market reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • CIBC World Market sold 46,880 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $18K.
  • CIBC World Market first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2016 and held it in 5 quarters.
  • CIBC World Market's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $51K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on CIBC World Market's 13F filing for Q2 2020, filed 13 Aug 2020.